Cynata Therapeutics Limited
CYYNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,741 | -$3,650 | -$5,204 | -$4,541 |
| Dep. & Amort. | $146 | $137 | $140 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $108 | $152 | $150 | $78 |
| Change in WC | $86 | $0 | $390 | $0 |
| Other Non-Cash | -$395 | $436 | -$585 | -$390 |
| Operating Cash Flow | -$5,795 | -$2,925 | -$5,108 | -$4,853 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $50 | -$50 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$50 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$50 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $124 | $7,490 | $0 | $0 |
| Financing Cash Flow | $124 | $7,490 | $0 | $0 |
| Forex Effect | $212 | -$212 | $146 | -$147 |
| Net Chg. in Cash | -$10,508 | $10,508 | -$11,167 | -$2,500 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,508 | $0 | $11,167 | $0 |
| End Cash | $0 | $10,508 | $0 | -$2,500 |
| Free Cash Flow | -$5,745 | -$2,975 | -$5,108 | -$4,853 |